The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

A new study reveals how a critical imbalance in bile acids—the substances made by the liver that help digest fats—can trigger ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given the increased risk of death from cirrhosis-related complications in patients ...

The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma, a prevalent and deadly liver cancer in the U.S. CHECKMATE-9DW trial results showed improved ...

Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.

"But unlike the other more well-known type of primary liver cancer – Hepatocellular carcinoma - there isn’t an established link to liver cirrhosis, viral hepatitis, alcohol or other lifestyle ...

The FDA has granted full approval to Bristol Myers Squibb’s (BMS) dual immunotherapy regimen of Opdivo (nivolumab) plus Yervoy (ipilimumab) for adults with unresectable or metastatic hepatocellular ...

In early-stage HCC patients (BCLC 0 and A), CP mRNA was elevated in 67.9% of cases, outperforming AFP, which detected only 46 ...

Each year, some 500-550 people in Sweden are diagnosed with what is known as hepatocellular carcinoma, or HCC for short, which is the most common form of primary liver cancer, in other words ...

One liver cancer, hepatocellular carcinoma (HCC), is associated with CLD in about 15-25% of cases. While increasing awareness and screening of cancers has improved the ability to detect liver ...